Deals
Cancer Drugmaker Tesaro Is Said to Explore Potential Sale
- Tesaro working with advisers after receiving takeover interest
- Advisers have begun reaching out to other potential buyers
This article is for subscribers only.
Tesaro Inc., a drugmaker whose shares tumbled this month after disclosing disappointing clinical trial results, is exploring a sale, according to people familiar with the matter.
The Waltham, Massachusetts-based company is working with financial advisers after receiving takeover interest, said the people, who asked not to be identified because the matter isn’t public. Advisers have also begun contacting other potential suitors, they said.